Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities

v3.24.1.1.u2
Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities - shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 2,059,971,417 1,997,216,731
Warrants [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 33,800,000 34,000,000
Series B preferred stock [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 419,369,203 324,240,164
Series C preferred stock [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 429,355,405 406,900,000
Convertible debt [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 1,170,101,111 1,206,660,749
Non-vested, forfeitable common shares [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 16,970,120
Stock options [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 7,345,698 8,445,698